Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption

Molecular Metabolism

Volumn 5, Issue 3, 2016, Pages 210-220

  Bowman, Thomas A ^a   O'Keeffe, Kayleigh R ^a   D'Aquila, Theresa ^c   Yan, Qing Wu ^a   Griffin, John D ^a   Killion, Elizabeth A ^a   Salter, Deanna M ^a   Mashek, Douglas G ^b   Buhman, Kimberly K ^c   Greenberg, Andrew S ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

ACSL; Acyl CoA; Dietary fat absorption; FGF21; Intestine; Liver

Indexed keywords

ACYL COENZYME A SYNTHETASE 5; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; INSULIN; LONG CHAIN FATTY ACID COENZYME A LIGASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BROWN ADIPOSE TISSUE; CALORIMETRY; CONTROLLED STUDY; DIET RESTRICTION; ENERGY EXPENDITURE; ENZYME ACTIVITY; FAT MASS; FEMALE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; JEJUNUM MUCOSA; LIPID ABSORPTION; LIVER; MALE; METABOLIC RATE; MOUSE; NONHUMAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA GENE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY QUOTIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; UCP1 GENE; WESTERN BLOTTING;

EID: 84959130047     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2016.01.001     Document Type: Article

References (36)

1. Greenberg A.S., Coleman R.A., Kraemer F.B., McManaman J.L., Obin M.S., Puri V., et al. The role of lipid droplets in metabolic disease in rodents and humans. Journal of Clinical Investigation 2011, 121(6):2102-2110.
2. Savage D.B., Petersen K.F., Shulman G.I. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiological Reviews 2007, 87(2):507-520.
3. Glass C.K., Olefsky J.M. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metabolism 2012, 15(5):635-645.
4. Ebbert J.O., Jensen M.D. Fat depots, free fatty acids, and dyslipidemia. Nutrients 2013, 5(2):498-508.
5. Ellis J.M., Frahm J.L., Li L.O., Coleman R.A. Acyl-coenzyme A synthetases in metabolic control. Current Opinion in Lipidology 2010, 21(3):212-217.
6. Mashek D.G., Li L.O., Coleman R.A. Long-chain acyl-CoA synthetases and fatty acid channeling. Future Lipidology 2007, 2(4):465-476.
7. Mashek D.G., Li L.O., Coleman R.A. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. Journal of Lipid Research 2006, 47(9):2004-2010.
8. Oikawa E., Iijima H., Suzuki T., Sasano H., Sato H., Kamataki A., et al. A novel acyl-CoA synthetase, ACS5, expressed in intestinal epithelial cells and proliferating preadipocytes. Journal of Biochemistry 1998, 124(3):679-685.
9. Achouri Y., Hegarty B.D., Allanic D., Becard D., Hainault I., Ferre P., et al. Long chain fatty acyl-CoA synthetase 5 expression is induced by insulin and glucose: involvement of sterol regulatory element-binding protein-1c. Biochimie 2005, 87(12):1149-1155.
10. Haas J.T., Miao J., Chanda D., Wang Y., Zhao E., Haas M.E., et al. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. Cell Metabolism 2012, 15(6):873-884.
11. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. Journal of Clinical Investigation 2002, 109(9):1125-1131.
12. Bu S.Y., Mashek D.G. Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways. Journal of Lipid Research 2010, 51(11):3270-3280.
13. D'Aquila T., Sirohi D., Grabowski J.M., Hedrick V.E., Paul L.N., Greenberg A.S., et al. Characterization of the proteome of cytoplasmic lipid droplets in mouse enterocytes after a dietary fat challenge. PLoS One 2015, 10(5):e0126823.
14. Lee B., Fast A.M., Zhu J., Cheng J.X., Buhman K.K. Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice. Journal of Lipid Research 2010, 51(7):1770-1780.
15. Uchida A., Lee H.J., Cheng J.X., Buhman K.K. Imaging cytoplasmic lipid droplets in enterocytes and assessing dietary fat absorption. Methods in Cell Biology 2013, 116:151-166.
16. Zhu J., Lee B., Buhman K.K., Cheng J.X. A dynamic, cytoplasmic triacylglycerol pool in enterocytes revealed by ex vivo and in vivo coherent anti-Stokes Raman scattering imaging. Journal of Lipid Research 2009, 50(6):1080-1089.
17. Grevengoed T.J., Cooper D.E., Young P.A., Ellis J.M., Coleman R.A. Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation. FASEB Journal 2015 Nov, 29(11):4641-4653. [Epub 2015 Jul 28]. 10.1096/fj.15-272732.
18. Kim J.H., Lewin T.M., Coleman R.A. Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones. The Journal of Biological Chemistry 2001, 276(27):24667-24673.
19. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957, 226(1):497-509.
20. Frayn K.N., Maycock P.F. Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability. Journal of Lipid Research 1980, 21(1):139-144.
21. Spriet L.L., Heigenhauser G.J., Jones N.L. Endogenous triacylglycerol utilization by rat skeletal muscle during tetanic stimulation. Journal of Applied Physiology (1985) 1986, 60(2):410-415.
22. Markan K.R., Naber M.C., Ameka M.K., Anderegg M.D., Mangelsdorf D.J., Kliewer S.A., et al. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes 2014, 63(12):4057-4063.
23. Owen B.M., Ding X., Morgan D.A., Coate K.C., Bookout A.L., Rahmouni K., et al. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metabolism 2014, 20(4):670-677.
24. Fisher F.M., Kleiner S., Douris N., Fox E.C., Mepani R.J., Verdeguer F., et al. FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes & Development 2012, 26(3):271-281.
25. Holland W.L., Adams A.C., Brozinick J.T., Bui H.H., Miyauchi Y., Kusminski C.M., et al. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metabolism 2013, 17(5):790-797.
26. Uchida A., Whitsitt M.C., Eustaquio T., Slipchenko M.N., Leary J.F., Cheng J.X., et al. Reduced triglyceride secretion in response to an acute dietary fat challenge in obese compared to lean mice. Frontiers in Physiology 2012, 3:26.
27. Uchida A., Slipchenko M.N., Cheng J.X., Buhman K.K. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, alters triglyceride metabolism in enterocytes of mice. Biochimica et Biophysica Acta 2011, 1811(3):170-176.
28. Bunger M., van den Bosch H.M., van der Meijde J., Kersten S., Hooiveld G.J., Muller M. Genome-wide analysis of PPARalpha activation in murine small intestine. Physiological Genomics 2007, 30(2):192-204.
29. Emanuelli B., Vienberg S.G., Smyth G., Cheng C., Stanford K.I., Arumugam M., et al. Interplay between FGF21 and insulin action in the liver regulates metabolism. Journal of Clinical Investigation 2014, 124(2):515-527.
30. Bu S.Y., Mashek M.T., Mashek D.G. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. The Journal of Biological Chemistry 2009, 284(44):30474-30483.
31. Rakhshandehroo M., Hooiveld G., Muller M., Kersten S. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS One 2009, 4(8):e6796.
32. Badman M.K., Pissios P., Kennedy A.R., Koukos G., Flier J.S., Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metabolism 2007, 5(6):426-437.
33. Inagaki T., Dutchak P., Zhao G., Ding X., Gautron L., Parameswara V., et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metabolism 2007, 5(6):415-425.
34. Forner F., Kumar C., Luber C.A., Fromme T., Klingenspor M., Mann M. Proteome differences between brown and white fat mitochondria reveal specialized metabolic functions. Cell Metabolism 2009, 10(4):324-335.
35. Yu X.X., Lewin D.A., Forrest W., Adams S.H. Cold elicits the simultaneous induction of fatty acid synthesis and [beta]-oxidation in murine brown adipose tissue: prediction from differential gene expression and confirmation in vivo. FASEB Journal 2002, 16(2):155-168.
36. Meller N., Morgan M.E., Wong W.P., Altemus J.B., Sehayek E. Targeting of Acyl-CoA synthetase 5 decreases jejunal fatty acid activation with no effect on dietary long-chain fatty acid absorption. Lipids in Health and Disease 2013, 12:88.